Zenith Drugs Ltd
Zenith Drugs Ltd Share Price Today: Live Updates & Key Insights
Get insights on Zenith Drugs Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Zenith Drugs Ltd Share Price Chart
null at 10 Jul 2026 06:36 PM null
N/A 0.00(0.00%)
Lowest Today 0.00
Highest Today 0.00
Today's Open 0.00
Prev. Close 0.00
52 Week High 0.00
52 Week Low 0.00
Zenith Drugs Ltd Fundamentals
Traded Volume: N/A
Market Cap(Cr): N/A
Avg Traded Price N/A
1 Year return %
Upper Circuit N/A
Lower Circuit N/A
P/E TTM 0.00
P/B Ratio 0.00
Traded Value(Cr) N/A
EPS TTM NaN
Book value/Share NaN
Dividend Yield 1Y 0.00%
Zenith Drugs Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Zenith Drugs Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Zenith Drugs Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -3.44%
1M +14.32%
3M +19.76%
1Y 0.00%
YTD -1.39%
Zenith Drugs Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Zenith Drugs Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 6400.00
Day Before Yesterday 18400.00
1W Avg 18400.00
1M Avg 14323.81
3M Avg 11672.13
Zenith Drugs Ltd Technical Details
Zenith Drugs Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 N/A
Support 2 N/A
Support 3 N/A
Pivot Point : N/A
Resistance 1 N/A
Resistance 2 N/A
Resistance 3 N/A
Zenith Drugs Ltd Corporate Actions
Zenith Drugs Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Zenith Drugs Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by null
Bonus
No Bonus has been declared by null
Splits
No Split has been declared by null
Others
Rights No Rights has been declared by null
Zenith Drugs Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Zenith Drugs Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Zenith Drugs Ltd's relative performance and valuation against major competitors.
Stock Name Mercury Laboratories Ltd ₹809.00 (+0.87%) M. Cap (Cr) 0.97 1 Yr Return (%) -5.93% P/E (TTM) 20.08 PB Ratio 1.67
Stock Name Concord Drugs Ltd ₹70.80 (-1.41%) M. Cap (Cr) 0.93 1 Yr Return (%) +21.55% P/E (TTM) 88.50 PB Ratio 1.92
Stock Name Makers Laboratories Ltd ₹149.90 (-2.73%) M. Cap (Cr) 0.88 1 Yr Return (%) -3.88% P/E (TTM) 37.20 PB Ratio 1.20
Stock Name Zenith Drugs Ltd ₹49.10 (-1.21%) M. Cap (Cr) 0.84 1 Yr Return (%) -28.74% P/E (TTM) 21.36 PB Ratio 1.12
Stock Name Curis Lifesciences Ltd ₹100.70 (0.00%) M. Cap (Cr) 0.81 1 Yr Return (%) NaN% P/E (TTM) 11.77 PB Ratio 1.72
Stock Name Amwill Health Care Ltd ₹41.00 (-3.91%) M. Cap (Cr) 0.82 1 Yr Return (%) NaN% P/E (TTM) 7.15 PB Ratio 1.01
Stock Name Samrat Pharmachem Ltd ₹254.00 (-0.06%) M. Cap (Cr) 0.78 1 Yr Return (%) -33.22% P/E (TTM) -23.70 PB Ratio 1.15
Zenith Drugs Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Zenith Drugs Ltd, across its operating activities, investing activities, and financing activities.
Zenith Drugs Ltd Shareholding Pattern
This shows the ownership breakdown of Zenith Drugs Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Zenith Drugs Ltd
Zenith Drugs Limited was originally incorporated on November 15, 2000 as a Private Limited Company as Zenith Drugs Private Limited issued by the Registrar of Companies, in the State of Madhya Pradesh, Gwalior. Subsequently, Company was converted into Public Limited and consequently, the name of the Company was changed to `Zenith Drugs Limited' pursuance to issuance of a Fresh Certificate of Incorporation on September 13, 2023 by the Registrar of Companies, Gwalior. Zenith are a reputable pharmaceutical manufacturing and trading unit based out from Indore. Zenith's core business centers on productionof high-quality, cost-effective pharmaceutical formulations such as: ORS Powder; Liquid Orals; Oinments; Liquid Externals and Capsules. With a diverse portfolio of formulations, the Company is specialized in manufacturing affordable and high quality medicines to meet the needs of patients. The Company was established in 2000 by the founders, Late Shri Ramniklal Soni, and Mr. Mukesh Jain. Initially in 2001, Company started as a modest manufacturing house for oral and external formulations. However, recognizing the importance of quality and compliance, the Company swiftly shifted to a Schedule M GMP compliant unit in 2004 where it started the production of two lines which are liquid orals and ointments. In 2007, it expanded the product line by incorporating ORS Powder manufacturing into their operations. In 2016, the Company established present manufacturing facility, which holds WHO GMP certification. In 2019, it expanded the product line by introducing liquid externals and capsules. The Company raised money from public by issuing 51,48,800 Equity Shares amounting to Rs 40.68 Cr. through fresh issue on February 22, 2024.In FY 2024-25, Company diversified its product portfolio by entering the tablet manufacturing segment and investing in new infrastructure to support this growth.Also, Company is in the process of establishing direct export distribution in Liberia for the product BVM's Oral Rehydration Salts B.P. 27.9g. This strategic initiative allows them to have more control over the export process and establish a direct presence in the Liberian market, ensuring seamless delivery of their products.
Managing Director
Sandeep Bhardwaj
Registered office K # 72/5 Village Muradpura, NA Depalpur, Indore, Madhya Pradesh, 453001
FAX :+91 84355 01867
Background
Incorporation Year 2000
Face Value ₹10.00
Market Lot 1600
FAQs on Zenith Drugs Ltd
How to buy Zenith Drugs Ltd shares?
To buy Zenith Drugs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Zenith Drugs Ltd?
The company has a market capitalization of ₹N/A.
What is the PE & PB ratio of Zenith Drugs Ltd?
PE is N/A and PB is N/A.
What is the Zenith Drugs Ltd dividend for 2025–26?
For the 2025–26 financial year, Zenith Drugs Ltd declared a final dividend of null% per share.